Thomas Lion

Ludwig Boltzmann Institute for Cancer Research — Austria

Medicine · Health Sciences

53h-index10.9kcitations302works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Myeloid Leukemia Treatments(78), Chronic Lymphocytic Leukemia Research(52), Acute Myeloid Leukemia Research(39), Hematopoietic Stem Cell Transplantation(38), Virus-based gene therapy research(38)

Publications301 total

Impact of insertion/deletion mutations a3ecting the <i>ABL1</i> gene in Phpositive leukemias
Haematologica·2026Open Access
Scaled-up non-thermal plasma-generating device Plasmatico enables effective and harmless disinfection of personal protective equipment
Scientific Reports·2025Open Access
A Phase I/II Trial Investigating Autologous Polyclonal Treg Therapy Together with Donor Bone Marrow Infusion in HLA-Mismatched Kidney Transplantation
American Journal of Transplantation·2025
Management of children and adolescents with chronic myeloid leukemia in chronic phase: International pediatric chronic myeloid leukemia expert panel recommendations
Leukemia·2025· 8 cited
P-103. Adenoviremia Clearance Following Treatment with Intravenous (IV) Brincidofovir (BCV) in Immunocompromised Patients is Associated with Positive Clinical Disease Response: Preliminary Outcomes from the ATHENA Phase IIa Study
Open Forum Infectious Diseases·2025· 1 citedOpen Access
Impact of Recent Translational and Therapeutic Developments on Clinical Course of <i>BCR::ABL1‐</i> Positive and ‐Negative Myeloproliferative Neoplasms
Hematological Oncology·2025Open Access
Integrated multi-omics identifies pathways governing interspecies interaction between A. fumigatus and K. pneumoniae
Communications Biology·2024· 2 citedOpen Access
Differential <i>in Vitro</i> Sensitivity of BCR::ABL1 Kinase Domain Mutations to Tyrosine Kinase Inhibitors Depending on the p190 or p210 Background
Blood·2024
New Insights in Current Practice in the Management of DNA Viruses in Children Following Allogeneic HSCT at EBMT Centers
Blood·2024
Phase I/IIa Trial of Autologous Regulatory T Cell Therapy Together with Donor Bone Marrow Infusion in Kidney Transplantation
Journal of the American Society of Nephrology·2024
CAR-T cells for the treatment of pediatric chronic myeloid leukemia in repeatedly relapsed lymphoid blast phase
Annals of Hematology·2024· 3 citedOpen Access
3D-printed devices for optimized generation of cold atmospheric plasma to improve decontamination of surfaces from respiratory pathogens
International Journal of Bioprinting·2024· 2 citedOpen Access
Prevalence of fungal DNAemia mediated by putatively non-pathogenic fungi in immunocompromised patients with febrile neutropenia: a prospective cohort study
Journal of Hematology & Oncology·2024· 1 citedOpen Access
Combination cell therapy leads to clonal deletion of donor-specific T cells in kidney transplant recipients
EBioMedicine·2024· 1 citedOpen Access
15 years Ludwig Boltzmann Institute for Hematology and Oncology (LBI HO): achievements and future perspectives
memo - Magazine of European Medical Oncology·2024Open Access
Comparative transcriptomics coupled to developmental grading via transgenic zebrafish reporter strains identifies conserved features in neutrophil maturation
Nature Communications·2024· 19 citedOpen Access
Preliminary Results of a Phase 2a Clinical Trial to Evaluate Safety, Tolerability and Antiviral Activity of Intravenous Brincidofovir (BCV IV) in Immunocompromised Patients with Adenovirus Infection
Transplantation and Cellular Therapy·2024· 8 cited
Combinatorial treatment options for highly resistant compound mutations in the kinase domain of the <scp>BCR</scp>::<scp>ABL1</scp> fusion gene in Ph‐positive leukemias
American Journal of Hematology·2023· 8 citedOpen Access
Proline catabolism is a key factor facilitating Candida albicans pathogenicity
PLoS Pathogens·2023· 16 citedOpen Access
Combinatorial Treatment Options for Highly Resistant Compound Mutations in the Kinase Domain of the BCR::ABL1 Fusion Gene
Blood·2023Open Access
page 1 of 16Next →

Frequent Co-authors

Susanne Matthes‐Martin(12), Christina Peters(12), Helmut Gadner(12), Ánita Lawitschka(10), G. Fritsch(10), Sandra Preuner(8), Franz Watzinger(6), Karin Ebner(5), H Daxberger(5), Margit Rauch(5), Oskar A. Haas(5), Karin Kosulin(4), Vincent H. J. van der Velden(3), Jacques J. M. van Dongen(3), Magdalena Suda(3), Ulrike Pötschger(3), Thoralf Lange(3), Giovanni Martinelli(3), Gisela Barbany(3), Tomasz Sacha(3)